BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 21820442)

  • 1. HIV Tat protein inhibits hERG K+ channels: a potential mechanism of HIV infection induced LQTs.
    Bai YL; Liu HB; Sun B; Zhang Y; Li Q; Hu CW; Zhu JX; Gong DM; Teng X; Zhang Q; Yang BF; Dong DL
    J Mol Cell Cardiol; 2011 Nov; 51(5):876-80. PubMed ID: 21820442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of IKr and its trafficking disruption induced by probucol in cultured neonatal rat cardiomyocytes.
    Guo J; Massaeli H; Li W; Xu J; Luo T; Shaw J; Kirshenbaum LA; Zhang S
    J Pharmacol Exp Ther; 2007 Jun; 321(3):911-20. PubMed ID: 17377062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of azelastine on cardiac repolarization of guinea-pig cardiomyocytes, hERG K⁺ channel, and human L-type and T-type Ca²⁺ channel.
    Park MH; Lee SH; Chu DH; Won KH; Choi BH; Choe H; Jo SH
    J Pharmacol Sci; 2013 Sep; 123(1):67-77. PubMed ID: 24005046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of zolpidem-induced long QT syndrome: acute inhibition of recombinant hERG K(+) channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cells.
    Jehle J; Ficker E; Wan X; Deschenes I; Kisselbach J; Wiedmann F; Staudacher I; Schmidt C; Schweizer PA; Becker R; Katus HA; Thomas D
    Br J Pharmacol; 2013 Mar; 168(5):1215-29. PubMed ID: 23061993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular interaction of droperidol with human ether-a-go-go-related gene channels: prolongation of action potential duration without inducing early afterdepolarization.
    Schwoerer AP; Blütner C; Brandt S; Binder S; Siebrands CC; Ehmke H; Friederich P
    Anesthesiology; 2007 May; 106(5):967-76. PubMed ID: 17457128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Febrile temperature facilitates hERG/IKr degradation through an altered K(+) dependence.
    Zhao Y; Wang T; Guo J; Yang T; Li W; Koichopolos J; Lamothe SM; Kang Y; Ma A; Zhang S
    Heart Rhythm; 2016 Oct; 13(10):2004-11. PubMed ID: 27321242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclovirobuxine D inhibits the currents of HERG potassium channels stably expressed in HEK293 cells.
    Zhao J; Wang Q; Xu J; Zhao J; Liu G; Peng S
    Eur J Pharmacol; 2011 Jun; 660(2-3):259-67. PubMed ID: 21497594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic-induced interstitial myocardial fibrosis reveals a new insight into drug-induced long QT syndrome.
    Chu W; Li C; Qu X; Zhao D; Wang X; Yu X; Cai F; Liang H; Zhang Y; Zhao X; Li B; Qiao G; Dong D; Lu Y; Du Z; Yang B
    Cardiovasc Res; 2012 Oct; 96(1):90-8. PubMed ID: 22853924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hERG K+ channel-associated cardiac effects of the antidepressant drug desipramine.
    Staudacher I; Wang L; Wan X; Obers S; Wenzel W; Tristram F; Koschny R; Staudacher K; Kisselbach J; Koelsch P; Schweizer PA; Katus HA; Ficker E; Thomas D
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Feb; 383(2):119-39. PubMed ID: 21120454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of HERG K+ channels by chronic exposure to activators and inhibitors of PKA and PKC: actions independent of PKA and PKC phosphorylation.
    Shu L; Zhang W; Su G; Zhang J; Liu C; Xu J
    Cell Physiol Biochem; 2013; 32(6):1830-44. PubMed ID: 24356123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clemastine, a conventional antihistamine, is a high potency inhibitor of the HERG K+ channel.
    Ridley JM; Milnes JT; Hancox JC; Witchel HJ
    J Mol Cell Cardiol; 2006 Jan; 40(1):107-18. PubMed ID: 16288909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-Tat induces a decrease in I
    Es-Salah-Lamoureux Z; Jouni M; Malak OA; Belbachir N; Al Sayed ZR; Gandon-Renard M; Lamirault G; Gauthier C; Baró I; Charpentier F; Zibara K; Lemarchand P; Beaumelle B; Gaborit N; Loussouarn G
    J Mol Cell Cardiol; 2016 Oct; 99():1-13. PubMed ID: 27590098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin inhibits hERG potassium channels in vitro.
    Hu CW; Sheng Y; Zhang Q; Liu HB; Xie X; Ma WC; Huo R; Dong DL
    Toxicol Lett; 2012 Jan; 208(2):192-6. PubMed ID: 22101212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H(1) antihistamine drug promethazine directly blocks hERG K(+) channel.
    Jo SH; Hong HK; Chong SH; Lee HS; Choe H
    Pharmacol Res; 2009 Nov; 60(5):429-37. PubMed ID: 19497368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of gefitinib-induced QT prolongation.
    Jie LJ; Li YD; Zhang HQ; Mao L; Xie HB; Zhou FG; Zhou TL; Xie D; Lin JL; Li GY; Cai BN; Zhang YH; Wang Y
    Eur J Pharmacol; 2021 Nov; 910():174441. PubMed ID: 34474028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Susceptibilities of Human Ether-à-Go-Go-Related Gene Channel with the G487R Mutation to Arrhythmogenic Factors.
    Hisajima N; Hata Y; Kinoshita K; Fukushima T; Nishida N; Kano M; Tabata T
    Biol Pharm Bull; 2015; 38(5):781-4. PubMed ID: 25947924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the human ether-a-go-go-related gene (hERG) potassium channel by Nedd4 family interacting proteins (Ndfips).
    Kang Y; Guo J; Yang T; Li W; Zhang S
    Biochem J; 2015 Nov; 472(1):71-82. PubMed ID: 26363003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluconazole inhibits hERG K(+) channel by direct block and disruption of protein trafficking.
    Han S; Zhang Y; Chen Q; Duan Y; Zheng T; Hu X; Zhang Z; Zhang L
    Eur J Pharmacol; 2011 Jan; 650(1):138-44. PubMed ID: 20951697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications.
    Thomas D; Karle CA; Kiehn J
    Curr Pharm Des; 2006; 12(18):2271-83. PubMed ID: 16787254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Block of hERG K+ channel and prolongation of action potential duration by fluphenazine at submicromolar concentration.
    Hong HK; Lee BH; Park MH; Lee SH; Chu D; Kim WJ; Choe H; Hee Choi B; Jo SH
    Eur J Pharmacol; 2013 Feb; 702(1-3):165-73. PubMed ID: 23395964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.